Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Edesa Biotech, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +4 vs. Q4 2024
- Shares held
- 2.82M
- +2.61M (+1,260.3%) vs. Q4 2024
- Total value
- $6.89M
- +$6.54M (+1,867.0%) vs. Q4 2024
- New holders
- 7
- 2 more added
- Sold out
- 3
- 3 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $30.0M |
| Q1 2026 | 28 | $13.8M |
| Q4 2025 | 22 | $4.34M |
| Q3 2025 | 23 | $7.10M |
| Q2 2025 | 20 | $4.28M |
| Q1 2025 | 20 | $6.89M |
| Q4 2024 | 17 | $350.1K |
| Q3 2024 | 18 | $718.2K |
| Q2 2024 | 17 | $645.1K |
| Q1 2024 | 17 | $450.9K |
| Q4 2023 | 19 | $507.1K |
| Q3 2023 | 20 | $1.26M |
| Q2 2023 | 22 | $1.63M |
| Q1 2023 | 26 | $2.05M |
| Q4 2022 | 22 | $3.53M |
| Q3 2022 | 21 | $494.2K |
| Q2 2022 | 24 | $2.26M |
| Q1 2022 | 23 | $5.51M |
| Q4 2021 | 26 | $2.03M |
| Q3 2021 | 23 | $2.85M |
| Q2 2021 | 18 | $1.37M |
| Q1 2021 | 16 | $773.7K |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Edesa Biotech, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 687,500 | $1.68M | 1.95% | +687,500 | New |
| Rubric Capital Management LP | 687,500 | $1.68M | 0.03% | +687,500 | New |
| Velan Capital Investment Management LP | 687,500 | $1.68M | 1.73% | +687,500 | New |
| Nantahala Capital Management, LLC | 625,000 | $1.52M | 0.13% | +625,000 | New |
| Commonwealth Equity Services, LLC | 50,003 | $122.0K | 0.00% | +50,003 | New |
| Geode Capital Management, LLC | 28,970 | $70.7K | 0.00% | +9,166+46.3% | Added |
| CIBC World Markets Inc. | 19,999 | $48.8K | 0.00% | +19,999 | New |
| Citadel Advisors LLC | 16,591 | $40.5K | 0.00% | −24,353−59.5% | Reduced |
| Vanguard Group Inc | 15,864 | $38.7K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,816 | $4.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,192 | $2.91K | 0.00% | −2,246−65.3% | Reduced |
| TD Waterhouse Canada Inc. | 142 | $329 | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 100 | $244 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 22 | $54 | 0.00% | +3+15.8% | Added |
| UBS Group AG | 4 | $10 | 0.00% | −27−87.1% | Reduced |
| Danske Bank A/S | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Credit Agricole S A | 1 | $2 | 0.00% | 00.0% | Unchanged |
| AllSquare Wealth Management LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Dogwood Wealth Management LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Avion Wealth | 242 | $0 | 0.00% | +242 | New |
| CM Management, LLC | 0 | $0 | 0.00% | −110,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,313−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |